• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate (CAS No. 595610-40-5): A Comprehensive Overview

Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate (CAS No. 595610-40-5) is a significant compound in the realm of pharmaceutical chemistry, exhibiting a unique structural framework that has garnered considerable attention from researchers worldwide. This compound, characterized by its ethyl ester functionality and a fused pyrazole ring system, has been extensively studied for its potential applications in drug discovery and medicinal chemistry.

The molecular structure of Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate consists of a pyrazole core substituted with a 4-chlorophenyl group at the 5-position and an ethyl ester at the 3-position. This arrangement imparts distinct chemical properties that make it a valuable scaffold for developing novel therapeutic agents. The presence of the chloro substituent on the phenyl ring enhances the electrophilicity of the molecule, facilitating various chemical transformations and interactions with biological targets.

In recent years, there has been a surge in research focusing on heterocyclic compounds, particularly those containing the pyrazole moiety. Pyrazoles are known for their broad spectrum of biological activities, including anti-inflammatory, antimicrobial, antiviral, and anticancer properties. Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate leverages these properties by serving as a versatile intermediate in the synthesis of more complex molecules designed to modulate specific biological pathways.

One of the most compelling aspects of Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate is its role in the development of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling and are often implicated in various diseases, including cancer. By designing molecules that selectively inhibit specific kinases, researchers aim to develop targeted therapies with improved efficacy and reduced side effects. The pyrazole core in Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate provides a scaffold that can be modified to interact with the active sites of kinases, making it an attractive candidate for further exploration.

Recent studies have highlighted the compound's potential in inhibiting Janus kinases (JAKs), which are involved in inflammatory responses and have been implicated in autoimmune diseases such as rheumatoid arthritis. Researchers have synthesized derivatives of Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate that exhibit potent JAK inhibition, demonstrating promising preclinical results. These findings underscore the compound's significance as a building block for developing novel anti-inflammatory agents.

The ethyl ester group in Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate also offers opportunities for further functionalization. Ester groups can be hydrolyzed to carboxylic acids or converted into other functional moieties, allowing for the creation of diverse chemical libraries. This flexibility makes it an invaluable intermediate in combinatorial chemistry and high-throughput screening programs aimed at identifying lead compounds for drug development.

In addition to its applications in kinase inhibition, Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate has shown promise in other therapeutic areas. For instance, its structural features make it a suitable candidate for developing antiviral agents. The pyrazole ring can interact with viral proteases and polymerases, potentially inhibiting viral replication. Furthermore, the chloro substituent can serve as a handle for further derivatization, enabling the design of molecules with enhanced antiviral activity.

The synthesis of Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate involves multi-step organic reactions that highlight its synthetic utility. The process typically begins with the condensation of appropriate precursors to form the pyrazole core, followed by functionalization with the 4-chlorophenyl group and introduction of the ethyl ester moiety. These synthetic routes are well-documented and can be optimized for large-scale production, ensuring a steady supply of the compound for research purposes.

The growing interest in Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate is reflected in the increasing number of patents and scientific publications reporting its use as an intermediate or lead compound. This trend underscores its importance as a tool in pharmaceutical research and development. As our understanding of biological pathways continues to expand, so too does the potential for this compound to contribute to the discovery of new treatments for various diseases.

In conclusion, Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate (CAS No. 595610-40-5) is a multifaceted compound with significant potential in pharmaceutical chemistry. Its unique structural features make it an excellent scaffold for developing novel therapeutic agents targeting various diseases, particularly those involving kinases and other enzymes critical to cell signaling pathways. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone in drug discovery efforts worldwide.

• 5932-30-9(Ethyl 3-phenyl-1H-pyrazole-5-carboxylate)
• 13599-12-7(Ethyl 3-phenylpyrazole-5-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)